methyldopa has been researched along with Behavior Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FULLERTON, AG; MORTON-JENKINS, D | 1 |
| Fleminger, R; Paykel, ES; Watson, JP | 1 |
| Johnson, JM | 1 |
| Borison, RL; Giardina, WJ; Mosnaim, AD; Pedemonte, WA; Sabelli, HC; Vazquez, AJ | 1 |
| Campanini, T; Catalano, A; De Risio, C; Forino, V | 1 |
| Nadel, I; Wallach, M | 1 |
| Sandifer, MG | 1 |
| Constantinidis, J | 1 |
| Calne, DB; Reid, JL | 1 |
| Horvath, TB; Meares, RA | 1 |
| Haefely, W | 1 |
5 review(s) available for methyldopa and Behavior Disorders
| Article | Year |
|---|---|
Psychiatric side effects of antihypertensive drugs other than reserpine.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Anxiety; Bethanidine; Clonidine; Debrisoquin; Depression; Dreams; Drug Interactions; Female; Ganglionic Blockers; Guanethidine; Hallucinations; Humans; Hydralazine; Hypotension; Male; Mental Disorders; Mental Processes; Methyldopa; Propranolol; Psychotropic Drugs; Sleep; Veratrum Alkaloids | 1982 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome | 1984 |
Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle.
Topics: 5-Hydroxytryptophan; Animals; Brain; Carbidopa; Deamination; Dihydroxyphenylalanine; Evoked Potentials; Humans; Mental Disorders; Methyldopa; Neural Inhibition; Neurons; Neurotransmitter Agents; Phenethylamines; Probenecid; Rabbits; Rats; Receptors, Drug; Synapses; Synaptic Transmission; Visual Perception | 1976 |
Antiparkinsonian drugs: pharmacological and therapeutic aspects.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission | 1972 |
[Drugs with effect on the adrenergic nerve fiber].
Topics: Aminocaproates; Amitriptyline; Amphetamine; Bretylium Compounds; Chlorpromazine; Disulfiram; Dopamine; Ephedrine; Guanethidine; Humans; Imipramine; Mental Disorders; Metaraminol; Methyldopa; Methyltyrosines; Monoamine Oxidase Inhibitors; Neurons; Norepinephrine; Octopamine; Prenylamine; Reserpine; Sympathetic Nervous System; Sympathomimetics; Tetrabenazine; Tyramine; Vascular Diseases | 1968 |
1 trial(s) available for methyldopa and Behavior Disorders
| Article | Year |
|---|---|
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome | 1984 |
7 other study(ies) available for methyldopa and Behavior Disorders
| Article | Year |
|---|---|
Methyldopa and depression.
Topics: Antihypertensive Agents; Depression; Depressive Disorder; Humans; Mental Disorders; Methyldopa; Psychoses, Substance-Induced; Psychotic Disorders | 1963 |
[Tardive dyskinesia. Synthetic-critical review and case contribution].
Topics: Adult; Aged; Baclofen; Dyskinesia, Drug-Induced; Female; Humans; Iatrogenic Disease; Male; Mental Disorders; Methyldopa; Middle Aged; Pyridoxine; Substance Withdrawal Syndrome; Tetrabenazine; Tranquilizing Agents; Valproic Acid | 1977 |
Drug interaction between haloperidol and methyldopa.
Topics: Aged; Aggression; Drug Interactions; Female; Haloperidol; Humans; Mental Disorders; Methyldopa | 1979 |
The hypertensive psychiatric patient: pharmacologic problems.
Topics: Antihypertensive Agents; Clonidine; Depression; Diuretics; Drug Interactions; Guanethidine; Humans; Hydralazine; Hypertension; Lithium; Mental Disorders; Methyldopa; Propranolol; Psychotropic Drugs; Reserpine | 1978 |
Psychiatric side effects of nonpsychiatric drugs.
Topics: Aminophylline; Analgesics; Anti-Anxiety Agents; Anti-Bacterial Agents; Anticonvulsants; Antiemetics; Antihypertensive Agents; Central Nervous System Stimulants; Chlordiazepoxide; Diazepam; Diuretics; Drug-Related Side Effects and Adverse Reactions; Furosemide; Histamine H1 Antagonists; Humans; Hypnotics and Sedatives; Insulin; Isoniazid; Mental Disorders; Methyldopa; Phenobarbital; Prednisone | 1971 |
[Monoamines and choreic syndromes].
Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine | 1972 |
The relevance of the neurophysiological concepts of excitation and inhibition to clinical psychiatry.
Topics: Acoustic Stimulation; Adolescent; Adult; Aged; Alcohol Amnestic Disorder; Anxiety; Arousal; Dihydroxyphenylalanine; Electroencephalography; Galvanic Skin Response; Habituation, Psychophysiologic; Humans; Hysteria; Mental Disorders; Methyldopa; Middle Aged; Obsessive-Compulsive Disorder; Parkinson Disease; Personality Inventory; Schizophrenia; Schizophrenia, Paranoid | 1973 |